DCAF10: Potential Drug Target and Biomarker for Diseases (G79269)

Target Name: DCAF10

NCBI ID: G79269

DCAF10

DCAF10: Potential Drug Target and Biomarker for Diseases

DCAF10 (Dynamic Contrast Analysis of Feedback) is a protein that is expressed in various tissues of the body, including the brain. It is involved in the regulation of cell proliferation and has been implicated in the development and progression of several diseases, including cancer.

One of the key functions of DCAF10 is its role in the regulation of cell proliferation. The protein is known to play a role in the G1/S transition, which is the process by which cells prepare for cell division. During this transition, DCAF10 helps to ensure that the cell is ready for cell division by regulating the activity of several key genes.

In addition to its role in cell proliferation, DCAF10 is also involved in the regulation of cell survival. The protein has been shown to play a role in the regulation of cell apoptosis, which is the process by which cells die naturally. This may be important for the regulation of cell life cycle and the development of cancer.

DCAF10 has also been shown to be involved in the regulation of cell migration. The protein helps to ensure that cells move in a specific direction and that they stick to the surface of the tissue they are in. This may be important for the development of tissue repair and regeneration.

In addition to its role in cell proliferation, DCAF10 is also involved in the regulation of several other cellular processes. For example, the protein has been shown to play a role in the regulation of protein synthesis, which is the process by which cells produce the proteins they need to function. It is also involved in the regulation of gene expression, which is the process by which cells express the instructions in their DNA.

DCAF10 is also involved in the regulation of cellular signaling pathways. The protein has been shown to play a role in several signaling pathways, including the TGF-β pathway and the Wnt pathway. These pathways are important for the regulation of cell growth, differentiation, and survival.

DCAF10 is also a potential drug target. The protein has been shown to play a role in the regulation of cell proliferation and has been implicated in the development and progression of several diseases, including cancer. Therefore, compounds that can inhibit the activity of DCAF10 may be useful for the treatment of these diseases.

In addition to its potential therapeutic applications, DCAF10 is also an interesting biomarker for the diagnosis and prognosis of several diseases. The protein has been shown to be involved in the regulation of several cellular processes, including cell proliferation, apoptosis, migration, and signaling pathways. Therefore, changes in the expression of DCAF10 may be an indicator of the severity or progression of certain diseases.

Overall, DCAF10 is a protein that is involved in several important cellular processes and has been implicated in the development and progression of several diseases. Therefore, compounds that can inhibit the activity of DCAF10 may be useful for the treatment of these diseases and may also be useful as biomarkers for the diagnosis and prognosis of these diseases.

Protein Name: DDB1 And CUL4 Associated Factor 10

Functions: May function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex

The "DCAF10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DCAF10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets